1. Applications of accelerator MS in pediatric drug evaluation. (August 2012) Authors: Vuong, LT; Blood, AB; Vogel, JS; Anderson, ME; Goldstein, B Journal: Bioanalysis Issue: Volume 4:Number 15(2012) Page Start: 1871 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Applications of accelerator MS in pediatric drug evaluation. (August 2012) Authors: Vuong, LT; Blood, AB; Vogel, JS; Anderson, ME; Goldstein, B Journal: Bioanalysis Issue: Volume 4:Number 15(2012) Page Start: 1871 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Applications of accelerator MS in pediatric drug evaluation. (August 2012) Authors: Vuong, LT; Blood, AB; Vogel, JS; Anderson, ME; Goldstein, B Journal: Bioanalysis Issue: Volume 4:Number 15(2012) Page Start: 1871 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Applications of accelerator MS in pediatric drug evaluation. (August 2012) Authors: Vuong, LT; Blood, AB; Vogel, JS; Anderson, ME; Goldstein, B Journal: Bioanalysis Issue: Volume 4:Number 15(2012) Page Start: 1871 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Applications of accelerator MS in pediatric drug evaluation. (August 2012) Authors: Vuong, LT; Blood, AB; Vogel, JS; Anderson, ME; Goldstein, B Journal: Bioanalysis Issue: Volume 4:Number 15(2012) Page Start: 1871 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The effects of genetic ablation of CaMKII oxidation on early ischemia-reperfusion arrhythmias in langendorff-perfused hearts. (10th June 2022) Authors: Haugsten Hansen, M; Sadredini, M; Hasic, A; Anderson, ME; Sjaastad, I; Korseberg Stokke, M Journal: Cardiovascular research Issue: Volume 118(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. CaMKII as a therapeutic target in catecholaminergic polymorphic ventricular tachycardia type 1. (24th May 2021) Authors: Sadredini, M; Manotheepan, R; Haugsten Hansen, M; Frisk, M; Louch, WE; Lehnart, SE; Anderson, ME; Sjaastad, I; Stokke, MK Journal: Europace Issue: Volume 23:Supplement 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗